Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of BP11 (Omalizumab Biosimilar) Compared To EU-Omalizumab And US-Omalizumab

Journal of Allergy and Clinical Immunology 2026 Open access

Read full text

Authors: Kiran Vasant Godse, Christopher John Wynne, Arpitkumar Prajapati, Disha Dadke

DOI: 10.1016/j.jaci.2025.12.350

Cited by: 0

Fields of Study & Subjects

Biosimilars and Bioanalytical Methods Monoclonal and Polyclonal Antibodies Research T-cell and B-cell Immunology